Trials / Sponsors / Molecular Targeting Technologies, Inc.
Molecular Targeting Technologies, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | 177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors Neuroendocrine Tumors | Phase 1 | 2022-06-18 |
| Completed | Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. Acute Coronary Syndrome | Phase 2 | 2008-10-01 |